IMF Videos Search Content For Healthcare Professional (76) Healthcare Provider (75) Care Partner (65) Patient (65) Series - Any - ASCO/EHA (31) ASH (30) Ask Dr. Durie (16) Community Workshops (3) Emerging Therapies (12) Facebook Live (6) Health Equity (4) IMWG (3) Living Well with Myeloma (3) Myeloma in a Minute (2) Myeloma Made Simple (6) Myeloma University (9) Q&A (6) Recent News and Developments (2) Treatments (1) Trending Searches in Myeloma (1) Topics Clinical Trials (184) Financial Considerations (15) Frontline Therapy (81) Health Equity (33) Inspirational Stories (23) Insurance (6) Lab & Imaging Tests (68) Lifestyle (47) Mental & Emotional Health (28) Myeloma 101 (54) Myeloma in the News (7) Public Policy & Advocacy (17) Q&A's (41) Recorded Seminars & Workshops (14) Recorded Webinars (23) Relapse/Refractory Myeloma (135) Research Updates (192) Symptom Management (113) Myeloma Stage Early Relapse (1–3 Lines of Therapy) (88) High-Risk Myeloma (38) High-risk Smoldering Myeloma (17) Late Relapse (4–6 Lines of Therapy) (101) MGUS (5) Newly Diagnosed (Pre-Treatment or First Treatment) (24) Smoldering Myeloma (13) Types of Therapy Immunomodulatory drugs (IMiDs) (31) Immunotherapies (CAR T; BiTE, etc.) (97) Monoclonal antibodies (33) Proteasome inhibitors (23) Stem cell transplant (24) Steroids (20) Supportive Care (36) Year Published 2026 (18) 2025 (22) 2024 (35) 2023 (39) 2022 (4) 2021 (4) 2020 (3) 2019 (2) 2018 (1) 2017 (1) 2016 (4) 2015 (2) Trusted Voices Dr. Joseph Mikhael (35) Dr. Brian GM Durie (15) Beth Faiman, PhD, MSN, APN-BC, AOCN®, BMTCN®, FAAN, FAPO (5) Donna Catamero, ANP-BC, OCN, CCRC (3) Dr. María-Victoria Mateos (2) Dr. Saad Usmani (2) Dr. Sagar Lonial (1) Dr. Tom Martin (1) Sort Newest firstOldest firstA -> ZZ -> ARelevance Key Abstracts Presented at ASCO and EHA 2025 August 1, 2025 ASCO/EHA IMF Virtual Myeloma Community Workshop (MCW): What’s Next? – Managing Myeloma at Relapse July 29, 2025 Community Workshops Linvoseltamab+Carfilzomib in Relapsed/Refractory Multiple Myeloma: LINKER-MM2 Trial Initial Results July 25, 2025 ASCO/EHA Relapsed Multiple Myeloma: What Every Patient Needs to Know July 24, 2025 Trending Searches in Myeloma Subcutaneous vs IV isatuximab + pomalidomide/dexamethasone in R/R MM: IRAKLIA phase 3 study July 21, 2025 ASCO/EHA Updated results from iMMagine-1: Phase 2 study of anitocabtagene autoleucel for relapsed/refractory multiple myeloma July 18, 2025 ASCO/EHA Top 10 Myeloma Breakthroughs from ASCO & EHA: Frontline Therapy, Early & Late Relapse, and CAR T-cell Insights July 17, 2025 Emerging Therapies Multiple Myeloma Q&A: Why Diagnosis Can Take 12+ Months, MGUS, Costs & FDA News July 10, 2025 Q&A Myeloma University | Bispecifics in Multiple Myeloma July 7, 2025 Myeloma University First-in-human JNJ-79635322 trispecific antibody study in RRMM patients: Initial phase 1 results June 19, 2025 ASCO/EHA IMWG Conference Series 2025: Making Sense of Treatment June 17, 2025 IMWG Infection Management for Bispecific Antibodies: A Patient’s Guide June 12, 2025 Myeloma Made Simple Load More
